Serum stem cell factor concentration in patients with myelodysplastic syndromes
Authors:
- 1 September 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 85 (1) , 63-66
Abstract
Summary. Stem cell factor (SCF) is characterized by its capacity to synergize dramatically with other haemopoietic growth factors in in vitro erythroid, myeloid, and lymphoid progenitor culture systems. We have measured serum SCF concentrations by enzyme immunoassay in 85 patients with myelodysplasia (MDS). Serum samples were taken in 1988–89 and in 1991–92 and stored at ‐20°C. Mean serum SCF concentration in the MDS patients was 2.81 ng/ml (range 0.6–8.0). This was significantly lower (P=0.0001) than the values for 234 normal subjects: mean 3.30 ng/ml (range 1.3–8. 0). No significant relationship between SCF concentration and peripheral blood counts, bone marrow parameters, red cell transfusion status, survival or FAB subtype was found, although a trend of decreasing SCF concentration from refractory anaemia through sideroblastic anaemia and chronic myelomonocytic leukaemia to refractory anaemia with excess blasts was seen. The reduced SCF serum concentration in some patients with myelodysplasia suggests a rationale for therapy with recombinant SCF in these patients.Keywords
This publication has 18 references indexed in Scilit:
- ErythropoietinNew England Journal of Medicine, 1991
- The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietinBritish Journal of Haematology, 1991
- Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutantCell, 1991
- The kit ligand: A cell surface molecule altered in steel mutant fibroblastsCell, 1990
- Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptorCell, 1990
- Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned mediumCell, 1990
- Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS)British Journal of Haematology, 1990
- FMS mutations in myelodysplastic, leukemic, and normal subjects.Proceedings of the National Academy of Sciences, 1990
- The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locusNature, 1988
- Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose‐concanavalin AJournal of Cellular Physiology, 1974